This systematic review with meta-analysis sought to determine the strength of evidence for effects of antioxidants (AO) such as N-acetyl cysteine (NAC), vitamin C, vitamin E, and alpha-lipoic acid on the incidence of contrast-induced nephropathy (CIN), requirement for haemodialysis, level of serum creatinine, and mortality after coronary angiography.
INTRODUCTION
Contrast-induced nephropathy (CIN) is a recognised complication after coronary angiography and percutaneous coronary intervention, which has been associated with morbidity, mortality, prolonged hospitalisation, and health care costs [1, 2] . CIN is the leading cause of hospital-acquired renal failure and requirement for haemodialysis in high-risk patients, such as those with history of chronic renal impairment, diabetic nephropathy, and heart failure, although the incidence of CIN is relatively low in the general population [3, 4] . CIN usually occurs during the first week and serum creatinine rises 24-48 h after exposure to radiocontrast agent [5] . Larger doses and intracoronary or intra-aortic injections of contrast agents can be associated with higher incidence of CIN [6] . The pathogenesis of CIN involves a combination of insults affecting renal tubular endothelial cells, such as intra-renal vasoconstriction and ischaemia, reperfusion injury, and toxicity of renal cells [7] [8] [9] [10] . Reperfusion injury can increase production of oxygen free radicals that exacerbate hypoxia-induced injuries of renal cells [7] [8] [9] [10] . Currently, the standard of care in the management of patients requiring coronary diagnostic imaging is sufficient hydration, minimisation of the volume of contrast agent, and careful use of nephrotoxic drugs [11] . Antioxidant (AO) supplementations such as N-acetyl cysteine (NAC), vitamin C, vitamin E, and alpha-lipoic acid are known as cytoprotective agents with scavenging action against oxygen free radicals that can also attenuate renal damage and inhibit pro-inflammatory markers, such as interlukin-10 and tumour necrosis factor-alpha [12] . This systematic review with meta-analysis sought to determine the strength of evidence for effects of anti-oxidants such as NAC, vitamin C, vitamin E, and alpha-lipoic acid on the incidence of CIN, requirement for haemodialysis, level of serum creatinine, and mortality after coronary angiography.
METHODS

Literature search
A comprehensive literature search was conducted in major electronic databases (Medline/Pubmed, Embase, Elsevier, Web of Knowledge, Sciences online database, and Google Scholar) from their inception through July 25, 2014 to identify randomised controlled trials (RCT) reporting on the effects of anti-oxidants on the incidence of CIN, requirement for haemodialysis, and level of serum creatinine. Predefined search terms included: "N-acetyl cysteine", "acetylcysteine", "NAC", "vitamin C", "ascorbic acid", "vitamin E", "tocopherol", "alpha-lipoic acid", and "contrast induced nephropathy", "CIN", "serum creatinine", "coronary angiography", "coronary imaging". No language restrictions were applied. All retrieved references of the included RCTs were also reviewed to determine additional studies not indexed in common databases. Studies were included into the analysis when they met the following criteria: 1) RCT, 2) comparison of AO supplementations with a control group, and 3) reporting data on the incidence of radiocontrast-induced complications according to our review-checklist. Congress presentations and abstracts without peer-review publications of manuscripts were not included in this review.
Data extraction and outcome measures
Three investigators (S.A.-H.-S., Z.G., and Z.S.) extracted the data independently, and discrepancies were resolved via a consensus standardised abstraction checklist used for recording data in each study. Data retrieved from the trials included: author's name, type of radiocontrast agent (low, iso, or high osmolality), type of anti-oxidant (NAC, vitamin C, vitamin E, and alpha-lipoic acid), details of dose and route of anti-oxidant regimens, details of hydration regimens, mean baseline serum creatinine, study design, sample size, mean age, and gender. The incidence of CIN, requirement for renal dialysis, mortality, and changes of creatinine serum levels were recorded for each group. For exploration of heterogeneity among the trials, a subgroup analysis of disparities in the patients' characteristics was performed for: 1) dose of anti-oxidants (for NAC: < 2400 mg, = 2400 mg and > 2400 mg), 2) type of administration (orally or intravenously), 3) radiocontrast agent type (low, iso, or high osmolality), and 4) type of angiography (elective, non-elective, both types, and no exact data).
Definitions
CIN was defined as ≥ 25% or ≥ 0.5 mg/dL increase in creatinine from baseline, and renal failure was defined as new onset of haemodialysis.
Statistical analysis, publication bias, and quality assessment Data were analysed by STATA version 11.0 utilising METAN and METABIAS modules. The effect sizes measured were odds ratio (OR) with 95% confidence interval (CI) for categorical variables. For non-categorical data the standard mean difference (SMD) with 95% CI was used for calculating differences in mean changes of serum creatinine between intervention and control groups. OR < 1 favoured supplementation, and OR > 1 favoured control. RCTs with no events in the two arms were discarded from pooled analysis. Forest plots were created for each outcome. A value of p < 0.1 for Q test or I 2 > 50% indicated significant heterogeneity among the studies. Heterogeneity among trials was accounted for by applying a random effect model when indicated. The presence of publication bias was evaluated using the Begg and Egger tests. Quality assessment of RCTs was performed using the Jadad score. The Jadad score [13] assesses three items including randomisation (0-2 points), blinding of study (0-2 points), and withdrawals and dropouts (0-1 points). Higher scores indicate better reporting ("high" quality: 5; "good" quality: 3-4; "poor" quality: 0-2). Results were considered statistically significant at p-values < 0.05.
RESULTS
Literature search strategy and included trials
The literature search retrieved 2350 studies from the screened databases, of which 1890 (80.4%) were excluded after initial review. Of the 460 primary included studies, 411 were excluded after detailed evaluation due to insufficient reporting of endpoints of interest. The final analysis included 49 RCTs.
Study characteristics and effect measures
Incidence of CIN. A total of 10,782 patients were included from 49 RCTs reporting data about all AO supplementations on incidence of CIN (Table 1 ) . The patient population of RCTs ranged from 30 to 2308 patients. From the 10,782 patients, 5395 were allocated to the AO group and 5387 to the control group. The overall incidence of CIN was 12.16%, ranging from 4.9% to 27.7%. CIN occurred in 10.5% in the AO group and in 13.7% in the control group (Table 2 ) . Pooled treatment effect analysis revealed that AO therapy significantly reduced the incidence of CIN with an OR of 0.75 (95% CI 0.67-0.85; p = 0.000) using a fixed model (Fig. 1) . No significant heterogeneity was observed among the RCTs (c 2 = 77.94, I 2 = 38.4%). A total of 8851 patients were included from 38 RCTs reporting data about NAC supplementation only on the incidence of CIN (Table 1) . Pooled treatment effect analysis revealed that NAC therapy significantly reduced the incidence of CIN with an OR of 0.79 (95% CI 0.69-0.9; p = 0.000) using a fixed model (Suppl. Fig. 1 ). No significant heterogeneity was observed among the RCTs (c 2 = 65.62, I 2 = 43.6%). A subgroup analysis showed that NAC had more preventing effects on CIN when administered orally compared to intravenous route, as well as dose ≤ 2400 mg NAC compared to > 2400 mg, and low-osmolality radiocontrast agents compared to iso or high osmolality agents (Table 3) . A total of 1243 cases were included from seven RCTs reporting data about vitamin C supplementation only on the incidence of CIN. Pooled treatment effect analysis revealed that vitamin C therapy significantly reduced the incidence of CIN with an OR of 0.63 (95% CI 0.45-0.89; p = 0.000) using a fixed model (Suppl. Fig. 2 ). No significant heterogeneity was observed among the RCTs (c 2 = 5.6, I 2 = 0%). Two RCTs for each of the other supplementations of vitamin E and alpha-lipoic acid were selected for the analysis (Table 1) . Pooled treatment effect analysis revealed that vitamin E therapy could significantly reduce the incidence of CIN with an OR of 0.5 (95% CI 0.27-0.92; p = 0.026) (Suppl. Fig. 3 ). However, alpha-lipoic acid failed to decrease the incidence of CIN with an OR of 0.5 (95% CI 0.20-1.67; p = 0.3) (Suppl. Fig. 4 ). Begg and Egger tests for studies about all AO supplementations showed that there was no potential publication bias among the included RCTs (Begg test, p = 0.076; Egger test, p = 0.076).
Requirement of haemodialysis.
A total of 7301 patients were included from 24 RCTs reporting data on requirement for haemodialysis (Table 1) . After removing 13 RCTs with no events in two arms, and one RCT about vitamin C, a total of 5468 patients were included in the meta-analysis from 10 studies on NAC supplementation. From 5468 patients, 2766 were allocated to the NAC group and 2702 to the control group. The overall incidence of requirement for haemodialysis was 0.51%, ranging from 0.25% to 2%. Requirement for haemodialysis occurred in 0.57% of the cases in the NAC group and 0.44% in the control group (Table 2) . Pooled treatment effect analysis revealed that NAC therapy could not reduce the incidence of requirement for haemodialysis after coronary angiography with an OR of 1.27 (95% CI 0.36-2.54; p = 0.4) using a fixed model (Fig. 2) . No significant heterogeneity was observed among the RCTs (c 2 = 4.34, I 2 = 0.0%).
Mortality Fourteen RCTs reported data on death. Mortality occurred in 2.67% in the AO group and 2.84% in control group (Table 1) . In fact, four out of 14 comparisons did not present any postoperative death event in two comparative arms; therefore, the remaining 10 RCTs (5658 patients) were used to perform the meta-analysis. The type of AO supplementation for 10 RCTs was NAC (Table 2) . Pooled treatment effect analysis revealed that AO supplementation therapy could not reduce the incidence of mortality with an OR of 0.94 (95% CI 0.69-1.28; p = 0.7) using a fixed model (Fig. 3) . No significant heterogeneity was observed among the RCTs (c 2 = 4.06, I 2 = 0.0%).
Mean changes of serum creatinine Mean changes of the level of serum creatinine for 30 trials were 0.08 ± 0.5 with 0.02 ± 0.51 for all AO and 0.13 ± 0.51 for the control group. From 4303 patients, 2133 were allocated to AO and 2170 to the control group (Tables 1, 2) . Pooled treatment effect analysis revealed that AO therapy could significantly prevent the increase of serum creatinine after angiography compared with baseline creatinine levels before the procedure, with an SMD of -0.128 (95% CI -0.189 --0.067; p = 0.000) using a random model. Significant heterogeneity was observed among the RCTs (c 2 = 76.25, I 2 = 62%). A total of 2999 patients were included from 24 RCTs reporting data about NAC supplementation only on mean changes of level of serum creatinine (Tables 1, 2) . Pooled treatment effect analysis revealed that NAC therapy significantly reduced mean level of serum creatinine with an SMD of -0.123 (95% CI -0.195 --0.051; p = 0.001) using a random model. A subgroup analysis showed that NAC had more decreasing effect on mean level of serum creatinine when administered orally compared to intravenously, as well as > 2400 mg NAC compared to ≤ 2400 mg, and low-osmolality radiocontrast agent compared to iso or high osmolality agents (Table 3) . Vitamin C Vitamin C orally 3 g at least 2 h before procedure, 2 g night before and morning after procedure. Hydration with NS 50-125 mL/h IV from time of randomisation to at least 6 h after procedure Non-ionic, low and iso osmolality contrast medium ALA at a dose of 600 mg orally every 8 h before coronary angiography (starting the afternoon prior to the procedure) and three times after angiography (beginning the afternoon on the day of the procedure). A total of 3600 mg of ALA was administered in six 600-mg doses Non-ionic, low and iso osmolality contrast medium 114 µmol/L ALA -alpha-lipoic acid; AO -anti-oxidant group; C -control group; IV -intravenously; N -number; NAC -N-acetyl cysteine; ND -no data; NS -normal saline; sCr -serum creatinine Table 1 . cont.. Demographic data of included studies. AO -anti-oxidant group; C -control group; CIN -contrast induced nephropathy; ND -no data A total of 896 cases were included from four RCTs reporting data about vitamin C supplementation only (Tables 1, 2) . Pooled treatment effect analysis demonstrated that vitamin C therapy could not reduce mean level of serum creatinine with an SMD of -0.08 (95% CI -0.22 --0.04; p = 0.1) using a fixed model. A total of 408 patients were included from two RCTs reporting data about vitamin E supplementation only. Pooled treatment effect analysis indicated that vitamin E therapy could not decrease mean level of serum creatinine with an SMD of -0.25 (95% CI -0.46 --0.05; p = 0.1) using a fixed model.
DISCUSSION
In the present study, the effects of antioxidants such as NAC, vitamin C, vitamin E, and alpha-lipoic acid on the incidence of CIN, requirement for haemodialysis, level of serum creatinine, and mortality were investigated. The results of our study revealed that antioxidants in general were able to significantly reduce the incidence of CIN after angiography. The effect of NAC supplementation was not dependent on a particular route of administration: both intravenous (IV) and oral administration were able to reduce CIN. Possibly the renal system response to NAC is dose-dependent since, according to our results, doses equal to or less than 2400 mg of NAC reduced CIN significantly while such prophylactic effects were not seen with higher doses. Interestingly, Marenzi et al. [63] also reported that the pattern of response to NAC was dose-dependent in patients undergoing percutaneous coronary interventions. However, in contrast to our study, higher doses of NAC had more significant effects in terms of prevention of CIN. Nevertheless, the mechanisms underlying the improvement of outcomes are not yet completely understood, so the issue regarding the optimal NAC dose should be elaborated in further studies. A subgroup analysis revealed that the least incidence of CIN following NAC administration was when the patients underwent low osmolality radiocontrast angiography with an adequate hydration plus NAC. Therefore, iso-osmolality radiocontrast not only increases the incidence of CIN, but also prevents the appearance of NAC effects. Loomba et al. [64] pointed out that NAC might be able to reduce the incidence of CIN if administered intravenously; however, this was not the case for oral administration. The present study indicated that vitamin C could reduce CIN significantly. A subgroup Figure 2 . Forest plot of odds ratio (OR) for effects of antioxidants on incidence of requirement dialysis; AA -ascorbin acid; AO -anti-oxidant group; CI -confidence interval; NAC -N-acetyl cysteine Figure 3 . Forest plot of odds ratio (OR) for effects of antioxidants on incidence of mortality; CI -confidence interval; NAC -N-acetyl cysteine analysis showed that the lowest incidence of CIN following vitamin C administration was when the patients underwent low osmolality radiocontrast angiography with adequate hydration plus vitamin C. In another study, Zhou et al. [57] argued that bioavailability and maintenance time of oral and IV administrations were not similar; therefore, oral high-dose vitamin C could have antioxidant effects on renal function. Vitamin E and alpha-lipoic acid each had only two related studies, which had found vitamin E to significantly reduce CIN while alpha-lipoic acid showed just a trend towards decreased CIN. CIN following angiography could predispose the incidence of renal failure and the requirement of dialysis in high-risk patients such as those with a history of chronic renal impairment, diabetic nephropathy, and heart failure [3, 4] . Despite the low incidence of requirement for dialysis, it is of high importance because the patients with this complication generally become prone to morbidity, suffer a decrease in quality of life, and an increase in the requirement for renal transplantation. Our findings indicated that the incidence of requirement for haemodialysis was 0.51% in general, and AO administration could not decrease this complication. Therefore, although AO administration can generally reduce CIN, it does not have a significant reducing effect on the incidence of requirement for haemodialysis. This result may be explained by the fact that in patients requiring dialysis in the period of follow-up, in addition to a history of renal disease before angiography, renal cell toxicity becomes too severe after exposure to radiocontrast agent, leading to a crisis of symptoms and higher incidence of severe CIN. This condition is malignant to such an extent that not only hydration, but also pharmacotherapy and supplements cannot have protective effects. Loomba et al. [64] reported that the decrease in CIN following AO administration may be negligible, despite being significant, because there was a very small difference in OR and no significant difference on clinical endpoints, such as need for dialysis and mortality. A study carried out by Albabtain et al. [15] showed that use of ascorbic acid, NAC, or a combination of both drugs could not be superior than the standard hydration in preventing CIN or renal function deteriorations parameters. Despite the absence of side effects, their findings did not warrant the use of antioxidants as a standard of care to prevent CIN. Another study conducted by Brueck et al. [54] indicated that there was no evidence that standard dosage of NAC or ascorbic acid administered intravenously the day before and on the day of contrast dye exposure provided any benefit over placebo with respect to CIN prevention in patients with renal insufficiency undergoing cardiac catheterisation. They suggested that correct indication for the contrast media administration, peri-procedural hydration, the use of a small amount of low-osmolality contrast agent, and the avoidance of repetitive administration of closely spaced contrast dye remain the most important determinants in the prevention of CIN. Changes in creatinine levels within 24 h to 48 h after exposure to radiocontrast agents could be considered as an equivalent indicator for new onset CIN. Therefore, an increase of 0.5 mg/dL after angiography demonstrates acute nephropathy. NAC but no vitamin C and vitamin E could significantly reduce the mean creatinine level within 48 h after angiography.
CONCLUSIONS
Our analysis showed that NAC can decrease mean changes of creatinine levels in elective coronary angiography compared to non-elective. Our findings confirmed that application of low osmolality radiocontrast agents led to less rise in creatinine levels in comparison with iso and high osmolality agents. If AOs are used following a low osmolality radiocontrast imaging, they have more protective effects. Finally, it is concluded that AOs such as NAC, vitamin C, and vitamin E could reduce the incidence of CIN. NAC but not vitamin C and vitamin E could decrease serum creatinine levels after coronary angiography, while AO administration could not decrease the requirement for haemodialysis and mortality. Also, this study suggested that coronary angiography performed using lower osmolality radiocontrast agents with adequate hydration and administration of antioxidant supplements could significantly prevent acute renal complications.
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